HUNTINGTON NATIONAL BANK

Bank

Position in CRNX — Crinetics Pharmaceuticals, Inc.

CIK 49205 COLUMBUS, OH

Position in CRNX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$20,393

-$418 QoQ

Shares Held

545

-4.9% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#209

of 264 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HUNTINGTON NATIONAL BANK holds $19,857,554 across 103 Biotechnology names. CRNX ranks #33 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	27,754	$13,786,243
2	RPRX	Royalty Pharma plc	55,717	$3,124,052
3	REGN	Regeneron Pharmaceuticals, Inc.	750	$467,655
4	INCY	Incyte Corp	3,313	$375,560
5	LGND	Ligand Pharmaceuticals Inc	701	$221,579
6	TARS	Tarsus Pharmaceuticals, Inc.	3,446	$216,891
7	MRNA	Moderna, Inc.	1,596	$111,767
8	VKTX	Viking Therapeutics, Inc.	2,815	$109,813

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$20,393	545	-4.9%	Shares	Defined	2026-08-13
2026-03-31	$20,811	573	-7.4%	Shares	Defined	2026-05-15
2025-12-31	$28,814	619	+4.0%	Shares	Defined	2026-02-09
2025-09-30	$24,781	595	-5.1%	Shares	Defined	2025-11-12
2025-06-30	$18,032	627	+14.2%	Shares	Defined	2025-08-05
2025-03-31	$18,413	549	+10.9%	Shares	Defined	2025-05-14
2024-12-31	$25,309	495	-11.8%	Shares	Defined	2025-02-12
2024-09-30	$28,667	561	-3.3%	Shares	Defined	2024-11-06
2024-06-30	$25,978	580	-0.5%	Shares	Defined	2024-08-08
2024-03-31	$27,290	583	-31.3%	Shares	Defined	2024-05-03
2023-12-31	$30,207	849	-2.2%	Shares	Defined	2024-02-07
2023-09-30	$25,814	868	-27.2%	Shares	Defined	2023-11-08
2023-06-30	$21,497	1,193	+40.5%	Shares	Defined	2023-08-11
2023-03-31	$13,634	849	—	Shares	Defined	2023-05-10
No filing history on record for this holder in this stock.